Since the outbreak of COVID-19, the Indian pharma and chemicals stocks have taken the biggest leap of all times. The revenue of India’s leading specialty chemicals giant Aarti Industries (AILs) which essentially caters to the country’s pharma and agrochemical demand, have been impacted positively by the pandemic. Moreover, the non-essential services business which remained largely impacted due to reduced discretionary spending amid the economic crisis has started to recover gradually. The overall plant utilization of the company has inched up from 50% in April to 90% in September. The company’s Nitrotoluene and Hydrogenation plants are currently running at the operating efficiencies of 60-70% in Q2FY20.
